All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Glycaemic Control of Type 2 Diabetics with Insulin Glargine in Everyday Practice Type 2 diabetic patients poorly controlled on insulin detemir therapy benefit from switching to insulin glargine

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F13%3A10294245" target="_blank" >RIV/00064203:_____/13:10294245 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11130/13:10294245

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Glycaemic Control of Type 2 Diabetics with Insulin Glargine in Everyday Practice Type 2 diabetic patients poorly controlled on insulin detemir therapy benefit from switching to insulin glargine

  • Original language description

    Background: In the RESOLUTE study, we investigated whether patients, with type 2 diabetes (T2D) inadequately controlled with insulin detemir (DET) in combination with oral anti-diabetic drugs (OADs) would benefit from switching to insulin glargine (GLA)(plus OADs) in everyday clinical practice. Methods: We performed this prospective, multinational, non-interventional, six-month observational study between June 2010 and November 2011. T2D patients with HbA(1c) > 7 to 10% (<53 to 86 mmol/mol) treated forat least three months with DET combined with OADs were documented after switching to GLA at the physician's discretion. The primary endpoint was the change in HbA(1c) after six months. Results: Of 564 T2D patients included in the study, 511 (61% female)were eligible for analysis (mean age: 61.9 +/- 10.1 years, BMI 30.9 +/- 5.1 kg/m(2), duration of diabetes 9.2 +/- 5.9 years). HbA(1c) decreased from 8.4 +/- 0.8% (61 10 mmol/mol) at baseline to 7.3 +/- 1.0% (56 +/- 11 mmol/mol) (p < 0.00

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FB - Endocrinology, diabetology, metabolism, nutrition

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2013

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Diabetes, Stoffwechsel und Herz

  • ISSN

    1861-7603

  • e-ISSN

  • Volume of the periodical

    22

  • Issue of the periodical within the volume

    3

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    7

  • Pages from-to

    141-147

  • UT code for WoS article

    000344910400002

  • EID of the result in the Scopus database